Tony Anene-Maidoh, MD
Neurological Surgery · Newark, DENPI 1174818850
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Abbott at 49.1% of the total. Reporting peaked in 2023 at $2,931 and has fallen 84.3% since, to $460 in 2025.
Across 77 payments — averaging $91.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medical Device Business Services, Inc.$2K
- Globus Medical$777
- Medtronic$526
- Johnson & Johnson$272
- Nevro Corp.$251
- plus $169 from 4 others
What the payments were for
- Travel & lodging$3,78154%
- Food & beverage$3,27746%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $3,463 |
| Medical Device Business Services, Inc. | 8 | $1,600 |
| Globus Medical(2 entities) | 8 | $777 |
| Medtronic(2 entities) | 8 | $526 |
| Johnson & Johnson(2 entities) | 4 | $272 |
| Nevro Corp. | 2 | $251 |
| Si-bone, Inc. | 1 | $63 |
| Sanara Medtech Inc. | 1 | $56 |
| Pacira Pharmaceuticals Incorporated | 1 | $37 |
| Foundation Medicine, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neurological surgery providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclobenzaprine Hcl | 56 | $520 |
| Oxycodone Hcl | 69 | $428 |
| Gabapentin | 25 | $256 |
| Mupirocin | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Newark
- Leif-Erik BohmanNewark$5K
- Pawan RastogiNewark$1K
- Paul BoulosNewark$504
- Bikash BoseNewark$411
- Andrew LuksikNewark$262
- Magdy BoulosNewark$24
- James EvansWilmington$365K
- Jeffrey CampbellWilmington$63K
- Ashwini SharanWilmington$51K
- Dawn TartaglioneDover$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.